We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A New CRISPR-Engineered Cancer Model to Test Therapeutics

News   Oct 06, 2017 | Original story from Broad Institute

 
A New CRISPR-Engineered Cancer Model to Test Therapeutics

Credit : Susanna M. Hamilton, Broad Communications

 
 
 

RELATED ARTICLES

Reducing Heart Attack-induced Tissue Damage by 30%

News

Scientists have discovered that inhibiting the synthesis of a lipid in a mouse suffering a heart attack reduces the tissue damage by 30%.

READ MORE

Ethics of Ancient DNA

News

In recent years, the study of ancient DNA, also known as aDNA, has rapidly advanced, providing important insights into a range of biological, historical, and social questions. The National Science Foundation has awarded a $350,882 collaborative grant to an array of institutions to analyze the current ethical landscape of ancient DNA research.

READ MORE

Novel Drugs Could Improve Long-term Treatment of Poorly Controlled Asthma

News

Preclinical study findings suggest that targeting a promising bitter taste receptor with structurally distinct drugs could help prevent reduced therapeutic effectiveness over time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE